Samakind (Semaglutide)

Samakind (Semaglutide) 15 mg / 3 mL injection by Mankind Pharma is a GLP-1 receptor agonist used to treat type 2 diabetes and support medical weight management. Semaglutide therapy helps regulate blood glucose levels while also helping patients control appetite and reduce calorie intake.

The medication works by mimicking the hormone GLP-1, which naturally regulates insulin secretion and appetite signals in the body. Samakind stimulates insulin production when blood sugar rises and reduces glucagon release from the liver. These effects help stabilize blood glucose levels and prevent large spikes after meals.

Semaglutide also slows stomach emptying, which helps increase feelings of fullness. As a result, many patients experience reduced appetite and gradual weight loss during treatment.

Samakind is supplied in a 15 mg semaglutide / 3 mL cartridge, designed for convenient once-weekly injection using a pen device. The injection is typically administered subcutaneously in the abdomen, thigh, or upper arm.

Doctors often begin treatment with a lower dose and increase it gradually depending on patient response. Some individuals may experience temporary nausea or digestive discomfort during the early stages of therapy.

With weekly dosing and proven metabolic benefits, Samakind offers a convenient treatment option for patients seeking modern GLP-1 therapy for diabetes and weight management.